Published 2021 | Version v1
Publication

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

Description

In patients with Multiple Sclerosis (pwMS) disease-modifying therapies (DMTs) affects immune response to antigens. Therefore, post-vaccination serological assessments are needed to evaluate the effect of the vaccine on SARS-CoV-2 antibody response.

Additional details

Created:
April 14, 2023
Modified:
November 28, 2023